
Tolterodine tablets/ Capsules(IR & ER)
Form: Tablets/ Capsules(IR & ER)
Strength: IR: 1 mg, 2 mg; ER: 2mg, 4 mg
Reference Brands: Detrol, Detrol LA(US & EU)
Category: Multiple sclerosis
Tolterodine capsules and tablets, marketed as Detrol and Detrol LA, are approved in the US by the FDA and in the EU via EMA for overactive bladder treatment. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and manufacturing data, while the EMA ensures compliance with regional standards. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring thorough compliance supports timely approval, safe use, and global availability of tolterodine products, helping improve bladder control and patient quality of life worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
LamotriginevDispersible tablets
Strength: XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg
Form: Tablets(IR & ER)
Reference Brands: Lamictal, Lamictal XR(EU & US)
View Details Get EnquiryOxybutynin tstransdermal patch
Strength: 3.9 mg/24 hours
Form: transdermal patch
Reference Brands: Oxytrol, Oxytrol for Women(US & EU)
View Details Get EnquiryOxybutynin tablets
Strength: IR: 5 mg, 10 mg; ER: 5 mg, 10 mg
Form: Tablet(IR & ER)
Reference Brands: Ditropan, Oxybutynin XL(US)
View Details Get EnquiryDalfampridine
Strength: 10 mg
Form: Extended-Release tablets (XR)
Reference Brands: Ampyra(US)
View Details Get Enquiry